Clinical and Experimental Vaccine Research

  • 제11권1호
  • /
  • Pages.129-132
  • /
  • 2022
  • /
  • 2287-3651(pISSN)
  • /
  • 2287-366X(eISSN)
대한백신학회 (The Korean Vaccine Society)
권호 표지
DOI QR코드

DOI QR Code

Alopecia areata after COVID-19 vaccination

  • Giuseppe Gallo (Dermatology Unit, Department of Medical Sciences, University of Turin) ;
  • Luca Mastorino (Dermatology Unit, Department of Medical Sciences, University of Turin) ;
  • Luca Tonella (Dermatology Unit, Department of Medical Sciences, University of Turin) ;
  • Simone Ribero (Dermatology Unit, Department of Medical Sciences, University of Turin) ;
  • Pietro Quaglino (Dermatology Unit, Department of Medical Sciences, University of Turin)
  • 투고 : 2021.09.07
  • 심사 : 2021.11.11
  • 발행 : 2022.01.31
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

The coronavirus disease 2019 (COVID-19) vaccines are authorized for use in numerous countries worldwide. Several cutaneous findings are reported after severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) vaccination. Here, we report the case of a patient with a rapid onset of alopecia areata immediately after receiving the second dose of the COVID-19 vaccine. Alopecia areata is a common autoimmune disease leading to non-scarring hair loss. Among the many cutaneous adverse effects reported after the anti-SARS-COV2 vaccination, no episodes of alopecia areata have been described to date. In this paper, we report the first case of alopecia areata after COVID-19 vaccination described in the literature with a revision of cases of alopecia areata reported after other types of vaccination. Although the significance of these skin reactions is not yet known, further studies will certainly clarify whether the development of alopecia areata or other forms of immune-mediated reactions could represent a positive prognostic factor regarding immune protection from SARS-CoV-2.

키워드

참고문헌

  1. Strazzulla LC, Wang EHC, Avila L, et al. Alopecia areata: disease characteristics, clinical evaluation, and new perspectives on pathogenesis. J Am Acad Dermatol 2018;78:1-12.
  2. Moreno-Arrones OM, Lobato-Berezo A, Gomez-Zubiaur A, et al. SARS-CoV-2-induced telogen effluvium: a multicentric study. J Eur Acad Dermatol Venereol 2021;35:e181-3.
  3. Sgubbi P, Savoia F, Calderoni O, Longo R, Stinchi C, Tabanelli M. Alopecia areata in a patient with SARS-Cov-2 infection. Dermatol Ther 2020;33:e14295.
  4. Capalbo A, Giordano D, Gagliostro N, et al. Alopecia areata in a COVID-19 patient: a case report. Dermatol Ther 2021;34:e14685.
  5. Berbert Ferreira S, Gavazzoni Dias M, Berbert Ferreira R, Neves Neto AC, Trueb RM, Lupi O. Rapidly progressive alopecia areata totalis in a COVID-19 patient, unresponsive to tofacitinib. J Eur Acad Dermatol Venereol 2021;35:e411-2.
  6. FIvenson D. COVID-19: association with rapidly progressive forms of alopecia areata. Int J Dermatol 2021;60:127.
  7. Meo SA, Bukhari IA, Akram J, Meo AS, Klonoff DC. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna vaccines. Eur Rev Med Pharmacol Sci 2021;25:1663-9.
  8. McMahon DE, Amerson E, Rosenbach M, et al. Cutaneous reactions reported after Moderna and Pfizer COVID-19 vaccination: a registry-based study of 414 cases. J Am Acad Dermatol 2021;85:46-55.
  9. Catala A, Munoz-Santos C, Galvan-Casas C, et al. Cutaneous reactions after SARS-CoV-2 vaccination: a cross-sectional Spanish nationwide study of 405 cases. Br J Dermatol 2021 Jul 13 [Epub]. https://doi.org/10.1111/bjd.20639.
  10. Wise RP, Kiminyo KP, Salive ME. Hair loss after routine immunizations. JAMA 1997;278:1176-8.
  11. Sanchez-Ramon S, Gil J, Cianchetta-Sivori M, FernandezCruz E. Alopecia universalis in an adult after routine tetanus toxoid vaccine. Med Clin (Barc) 2011;136:318.
  12. Essam R, Ehab R, Al-Razzaz R, Khater MW, Moustafa EA. Alopecia areata after ChAdOx1 nCoV-19 vaccine (Oxford/AstraZeneca): a potential triggering factor? J Cosmet Dermatol 2021;20:3727-9.
  13. Lopez-Valle A, Falkenhain-Lopez D, Arranz CR. Cutaneous reaction to BNT162b2 mRNA COVID-19 vaccine. Int J Dermatol 2021;60:891-2.
  14. Jedlowski PM, Jedlowski MF. Morbilliform rash after administration of Pfizer-BioNTech COVID-19 mRNA vaccine. Dermatol Online J 2021;27:13030/qt4xs486zg.
  15. Chu CH, Cheng YP, Chan JY. Alopecia areata after vaccination: recurrence with rechallenge. Pediatr Dermatol 2016;33:e218-9.